Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Comp Neurol. 2016 Jan 26;524(11):2300–2321. doi: 10.1002/cne.23952

Table 1.

Primary antibodies used in this study.

Antibody Immunogen Source (RRID number) Dilution factor
Brn3b Human Brn3b Santa Cruz Biotechnology, #sc-31989, (RRID: AB_2167523), goat polyclonal 1:250
ChAT Human Placental ChAT Millipore, #AB144P, (RRID:AB_2079751), goat polyclonal 1:250
GFP GFP isolated from Aequorea victoria Millipore, #AB3080P, (RRID: AB_91338), rabbit polyclonal 1:500
GFP recombinant GFP Aves Labs, #GFP-1020, (RRID: AB_10000240), chicken polyclonal 1:500
ETV1 synthetic mouse C-terminal peptide Abcam, #ab36788, (RRID: AB_732196), rabbit polyclonal 1:2000
MBP Cow full length protein Abcam, #ab7349, (RRID: AB_305869), rat monoclonal 1:500
NeuN mouse brain nuclei Millipore, #MAB377, (RRID: AB_2298772), mouse monoclonal 1:1000
Parvalbumin rat muscle parvalbumin Swant, Switzerland, #PV25, (RRID: AB_10000344), rabbit polyclonal 1:2000
Substance P substance P-BSA Fitzgerald Industries International, #10-S15A, (RRID: AB_1288870), rat monoclonal 1:250
Somatostatin synthetic somatostatin peptide BACHEM (Peninsula lab), #T-4103.0050, (RRID: AB_518614), rabbit polyclonal 1:1000
HHS Vulnerability Disclosure